fda compounding semaglutide enforcement news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Important Update: Changes to Compounded

Through these receptors, GLP-1 helps regulate blood glucose, appetite, and body weight

If you're interested in optimizing your entire weight loss therapynot just storage practicesconsider adding the PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) to understand which peptide pathways your body responds to most effectively

When paired with moderate exercise, results amplify, with some achieving 15-25 pounds lost over three months

Cagrilintide Dosage with Retatrutide: Safety Considerations Overlapping Side Effect Profiles Both cagrilintide and retatrutide share remarkably similar adverse event patterns, raising legitimate concerns about potential additive effects when considering cagrilintide dosage with retatrutide combinations [9]

Avoid Agitation: Remember, peptides are not meant to be shaken